Skip to main content
. 2020 Jul 17;10:11876. doi: 10.1038/s41598-020-68516-y

Figure 8.

Figure 8

Percentage and geometric mean fluorescence intensity of cell subpopulations positive for neutral GSL with terminal Gal residue. Notes Percentage of CSCs in the MDA-MB-231 and in the MDA-MB-453 (A) and non-CSCs in MDA-MB 231 and in the MDA-MB-453 cell lines (B). Geometric mean fluorescence intensity of CSCs in MDA-MB 231 and in the MDA-MB-453 (C) and non-CSCs in the MDA-MB-231 and in MDA-MB-453 cell lines after treatment with compound 1 in duration of 48 h. Data are expressed as a mean from experiment performed in triplicate ± SD. Columns, mean of viable cells; bars, SD; *P < 0.05; **P < 0.01. CSC MDA-MB-231, CD44+CD24 cells of the MDA-MB-231 cell line; CSC MDA-MB-453, CD133+ cells of the MDA-MB-453 cell line; non-CSC MDA-MB-231, CD44+/CD24+, CD44/CD24 and CD44/CD24+ cells of the MDA-MB-231 cell line; non-CSC MDA-MB-453, CD133 cells of the MDA-MB-453 cell line; neolactotetraosylceramide or nLc4Cer. GMI, geometric mean fluorescence intensity; SD, standard deviation.